Navidea Biopharmaceuticals, Inc. Navidea Biopharmaceuticals, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Careers
  • Technology
    • Overview
    • Grant Funding
  • Pipeline
  • News & Media
    • Press Releases
    • Events
    • Publications
    • In the News
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Events
  • Publications
  • In the News

Navidea to Report Preliminary 2014 Revenue and Present at BIO CEO & Investor Conference February 9

Feb 2, 2015

Lymphoseek® Performance vs. Sulfur Colloid in Breast Cancer Patients Published in Annals of Surgical Oncology; Fewer Nodal Dissections Required

Jan 29, 2015

Navidea’s Macrophage Therapeutics Unit Announces Plan for $2.5 Million Financing

Jan 21, 2015

Navidea Biopharmaceuticals to Present at Biotech Showcase 2015

Jan 6, 2015

Navidea Strengthens Leadership Team to Accelerate Lymphoseek® Growth

Jan 5, 2015

Data Presented by Independent Academic Collaborators Demonstrate Ability of Novel Manocept™ Immunotherapy to Kill Activated Macrophages from KS Patients

Dec 15, 2014

Macrophage Therapeutics to Present Data Supporting Potential for Breakthrough with Manocept™ in Immunotherapy

Dec 12, 2014

Navidea Forms Macrophage Therapeutics Business Unit to Explore Therapeutic Applications of Manocept™

Dec 10, 2014

Navidea Biopharmaceuticals to Present at the 2014 LD Micro Conference

Nov 25, 2014

European Commission Approves Navidea’s Sentinel Lymph Node Detection Agent Lymphoseek®

Nov 20, 2014
    • 1...
    • 24
    • 25
    • 26
    • 27
    • 28
    • 29
    • 30
    • 31
    • 32
    • 33
    • ...45
    © 2025 Navidea Biopharmaceuticals, Inc. All Rights Reserved.
    linkedin
    Privacy Policy Disclaimer Sitemap